Overview

Drug to Drug Interaction Study With ASP1941 and Metformin

Status:
Completed
Trial end date:
2009-12-09
Target enrollment:
Participant gender:
Summary
A study to investigate the effect on safety, pharmacokinetics and pharmacodynamics when ASP1941 is administered as add-on therapy to metformin.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin
Metformin